NBC’s Dateline segment on new diet pills for weight loss was ripped on this blog:
“While this story naturally paints a rosy picture of weight-loss drugs, there are always potential problems. For instance, none of these drugs have yet been approved by the Food and Drug Administration, so there’s no telling when or if they will hit the market. The drugmakers report no serious side effects, but further study may pick something up.
The story only highlights people who had success with the drug, but such drugs never work dramatically for everyone. And, as is noted in the story, it’s possible that once someone is on one of these drugs, they’ll need to keep taking them for the long-term, perhaps even for life, to be able to keep the weight off. And at this point no one knows what effect that would have on the health of a patient.
So while it’s great to consider the possibilities of a weight-loss drug that makes it easy to lose however much excess weight you need to, it’s important to remember the reality isn’t always so rosy as the news stories would have you believe.”
Opinions on other issues in news, journals, PR, advertising, marketing
A lot of interesting workshops are happening now at the #NBCCSummit! @garyschwitzer, the publisher of @HealthNewsRevu, is discussing new cancer research news. #BeBold
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like